Douglas Yee MD

[Douglas Yee MD @DougYeeMD]

@ClaudeHorvath Thanks. Please be aware of this petition. https://t.co/UeRDrQvyEk

[Douglas Yee MD @DougYeeMD]

https://t.co/UeRDrQN9vS

[Douglas Yee MD @DougYeeMD]

Dale, thanks for teaching many of us about the importance of partnership with advocates.

[Dr. Steffi Oesterreich @oesterreichs]

@abreastcancer Thanks Dale for everything you have down for breast cancer patients and to push research forward! Definitely need more research on #dormancy! #lobular @LobularBCA #lobmob @abreastcancer #bcsm

[Douglas Yee MD @DougYeeMD]

IGF1R inhibitor approved for thyroid eye disease. A long road for this class of drugs.

[PharmaFactz @PharmaFactz]

Yesterday, teprotumumab-trbw (Tepezza) was FDA-approved for the treatment of thyroid eye disease; a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).

[Douglas Yee MD @DougYeeMD]

@jimjaxn100 How did you even know I joined?